Literature DB >> 8082411

In vitro sensitivity of medically significant Fusarium species to various antimycotics.

A S Sekhon1, A A Padhye, A K Garg, H Ahmad, N Moledina.   

Abstract

Sixteen isolates belonging to Fusarium chlamydosporum (n = 4), Fusarium equiseti (n = 1), Fusarium moniliforme (n = 2), Fusarium oxysporum (n = 3), Fusarium proliferatum (n = 1), and Fusarium solani (n = 5) were tested against amphotericin B, 5-fluorocytosine, fluconazole, itraconazole, ketoconazole, JAI-amphotericin B (water-soluble compound), hamycin and amphotericin B combined with 5-fluorocytosine, using antibiotic medium M3, high-resolution broth (pH 7.1), Sabouraud's dextrose, and yeast-nitrogen broth media (1 ml/tube). The minimal inhibitory and minimal fungicidal concentrations of 5-fluorocytosine and fluconazole for all species were > 100 micrograms/ml. All Fusarium isolates, except F. equiseti (3.125 micrograms), gave minimal inhibitory concentrations of 12.5-100 micrograms/ml for hamycin. The values for amphotericin B, itraconazole, ketoconazole, JAI-amphotericin B, and amphotericin B combined with 5-fluorocytosine were 1.56-100, 0.78-50, 3.125-100,50-100, and 1.56 to > 100 micrograms/ml, respectively. Although a wide range of minimal inhibitory concentrations was recorded for most of the isolates studied, it appears that some--F. solani, F. oxysporum, F. chlamydosporum, F. equiseti, and F. moliniforme--were more susceptible to amphotericin B, itraconazole, ketoconazole, hamycin, and amphotericin B in the presence of 5-fluorocytosine. All isolates showed resistance to 5-fluorocytosine and fluconazole. The minimal fungicidal concentrations were either the same or several times higher than the minimal inhibitory concentrations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8082411     DOI: 10.1159/000239199

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  12 in total

1.  In vitro and in vivo experimental activities of antifungal agents against Fusarium solani.

Authors:  J Guarro; I Pujol; E Mayayo
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Effects of incubation temperature, inoculum size, and time of reading on broth microdilution susceptibility test results for amphotericin B fgainst Fusarium.

Authors:  I Pujol; J Guarro; J Sala; M D Riba
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

3.  Cutaneous hyalohyphomycosis caused by Fusarium solani in a loggerhead sea turtle (Caretta caretta L.).

Authors:  F J Cabañes; J M Alonso; G Castellá; F Alegre; M Domingo; S Pont
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

4.  Treatment of murine fusariosis with SCH 56592.

Authors:  M Lozano-Chiu; S Arikan; V L Paetznick; E J Anaissie; D Loebenberg; J H Rex
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

5.  In vitro efficacy and fungicidal activity of voriconazole against Aspergillus and Fusarium species.

Authors:  C J Clancy; M H Nguyen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-08       Impact factor: 3.267

6.  Invasive infection with Fusarium chlamydosporum in a patient with aplastic anemia.

Authors:  B H Segal; T J Walsh; J M Liu; J D Wilson; K J Kwon-Chung
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

7.  Disseminated fusariosis secondary to neuroblastoma with fatal outcome.

Authors:  Gleiciere Maia Silva; Alice Rangel Cristiane Silveira; Claudia Abreu Rodrigues Betânia; Danielle Patrícia Cerqueira Macêdo; Rejane Pereira Neves
Journal:  Mycopathologia       Date:  2013-06-30       Impact factor: 2.574

Review 8.  Opportunistic fusarial infections in humans.

Authors:  J Guarro; J Gené
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

9.  Pharmacokinetics and safety of intravitreal caspofungin.

Authors:  Ying-Cheng Shen; Chiao-Ying Liang; Chun-Yuan Wang; Keng-Hung Lin; Min-Yen Hsu; Hon-Leung Yuen; Li-Chen Wei
Journal:  Antimicrob Agents Chemother       Date:  2014-09-22       Impact factor: 5.191

10.  [Skin infections caused by Fusarium].

Authors:  J Brasch
Journal:  Hautarzt       Date:  2012-11       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.